Four services. One system.
Every engagement we offer is designed to connect — not to solve one problem in isolation, but to build the decision architecture that makes better packaging choices possible across your organisation.
Service 01
SPARS Methodology
Our Sustainability Portfolio Assessment and Readiness Scorecard.
SPARS is the foundational diagnostic and strategic planning service we offer. It was designed specifically for healthcare and life sciences SMEs whose packaging portfolios have grown organically and now face mounting regulatory, cost, and sustainability pressure — without a clear picture of where the exposure actually sits.
We do not begin with materials. We begin with the decision architecture around the portfolio. That means understanding which SKUs exist and why, which materials are used across which products and markets, where the compliance gaps are, what the true cost of portfolio complexity is, and which functions currently own — or do not own — the decisions that need to be made.
The outcome is not a theoretical roadmap. It is a prioritised, pragmatic action plan that fits your team's capacity, your regulatory constraints, and your commercial priorities.
Self-Assessment
10 minutesFree online diagnostic. Understand where your portfolio stands against the key readiness dimensions: exposure, feasibility, regulatory pathway, supplier readiness, and decision rights.
Roadmap
2–3 weeksA detailed diagnostic of your portfolio, followed by a structured roadmap with prioritised actions, clear ownership, and defined timelines.
Full Strategy Workshop
4–6 weeksA cross-functional engagement that builds the shared decision architecture your teams need to move from awareness to action together.
Service 02
PPWR Readiness
The regulation is in force. The deadlines are not theoretical.
The EU Packaging and Packaging Waste Regulation (EU) 2025/40 entered into force in February 2025 and applies from August 2026. It introduces binding requirements on recyclability, recycled content, packaging minimisation, and Extended Producer Responsibility — with transition timelines that are already active.
The most common misconception we encounter in pharma and life sciences is that the sector is largely exempt. It is partially true. Certain primary pharmaceutical packaging has specific provisions and targeted exceptions where patient safety is the overriding concern. But that should not be confused with immunity from transition pressure. EPR obligations, recyclability requirements for secondary and tertiary packaging, and reporting responsibilities still apply — and the deadlines are real.
We help you understand exactly where your portfolio is exposed, what is required under the regulation, and how to build a compliance pathway that is proportionate to your business — without waiting until urgency removes your options.
What we assess
Portfolio exposure mapping
Which packaging formats, materials, and markets are subject to which PPWR requirements.
Gap analysis
Where your current portfolio falls short of the 2030 recyclability targets and recycled content thresholds.
EPR obligations
What your Extended Producer Responsibility reporting and financial obligations are, by market.
Compliance pathway
A prioritised, sequenced plan for closing the gaps, designed around your regulatory, operational, and commercial constraints.
Service 03
Circularity & Design Systems
Circularity fails when it is applied to products, not to portfolios.
The evidence is consistent. Up to 80% of a product's environmental impact is determined at the design phase. Once materials are chosen and formats are locked, the environmental footprint is fixed. Yet most organisations apply circular design principles to individual products, not to the portfolio as a system. The result is isolated wins that do not add up to systemic change.
The problem is compounded in healthcare and life sciences, where packaging decisions involve validated systems, regulatory pathways, patient safety requirements, and supplier dependencies that make change genuinely difficult. Circular design in this context is not a material substitution exercise. It is a cross-functional decision architecture challenge.
We help you build the frameworks that connect innovation, procurement, quality, regulatory, and operations around a shared set of design principles — so that sustainable choices are made consistently, not heroically.
What we build
Eco-design frameworks
Structured decision tools that embed environmental criteria into packaging development from the brief stage — not as a retrospective assessment.
Portfolio simplification
SKU rationalisation and material harmonisation to reduce complexity, lower procurement costs, and improve compliance manageability.
Cross-functional alignment
Governance structures and decision rights that allow trade-offs between sustainability, quality, regulatory, and commercial priorities to be made — and acted on.
Service 04
Future Thinking
The assumptions that made yesterday's decisions rational may not hold tomorrow.
Regulatory timelines are compressing. Material availability assumptions are shifting. Supply chains that were reliable are becoming fragile. The operating context that shaped your current packaging portfolio was designed for conditions that are changing — and many organisations are still planning from assumptions of stability that no longer hold.
Future Thinking is not about predicting what will happen. It is about testing whether the assumptions behind your current decisions remain defensible — and building the strategic clarity to act before urgency removes your options.